InvestorsHub Logo
Followers 40
Posts 4465
Boards Moderated 0
Alias Born 02/28/2018

Re: None

Friday, 11/27/2020 10:23:07 AM

Friday, November 27, 2020 10:23:07 AM

Post# of 113647
We Are the First and We Own a Game Changing Patent
MASSIVE BREAKTHROUGH

https://edtimes.in/sunshine-biopharma-makes-massive-breakthrough-to-tackle-the-deadly-coronavirus/




The team at Sunshine Biopharma was the first company to evaluate the SARS-CoV-2 protein PLpro, the virus that causes COVID-19 and destroys a human’s immune system. The compounds which were screened recently are based on the technology described in Sunshine Biopharma’s recently filed patent application covering small molecules which can be used to treat Coronavirus infections.

In September 2020

Ed Time Says

Moreover, Sunshine Biopharma is also developing its flagship anti-cancer compound called Adva-27a which is meant to destroy multidrug resistant cancer cells, including pancreatic cancer cells, small-cell lung cancer cells, breast cancer cells and uterine sarcoma cells. The mechanism by which Adva-27a is able to destroy cancer cells is through the inhibition of a key cell-cycle enzyme called Topoisomerase II. With thorough research, Sunshine Biopharma is running several clinical trials to curb these life-threatening diseases and the company is looked by the major pharmaceuticals of the world.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News